Mirle Schemionek-Reinders is new Professor of Biology

In her research activities, Schemionek-Reinders focussed on the therapeutic resistance of stem cells in malignant diseases of the blood and lymphatic system. "We have the Institute for Genetic Analysis. This is a good framework in which Professor Schemionek-Reinders will work and contribute to the reputation of science and the university," said President Hartmut Ihne on the occasion of her appointment. With her research to date, she has contributed to the realisation that malignant stem cells can survive despite targeted therapy. The aim of her further research is to identify new target structures that enable the therapeutic elimination of malignant stem cells.

Since 2012, Schemionek-Reinders has been Head of Molecular Diagnostics at the Department of Haematology, Oncology, Haemostaseology and Stem Cell Transplantation at RWTH Aachen University Hospital, where she introduced molecular genetic methods into the diagnosis of haematological diseases.

In 2020, Schemionek-Reinders habilitated at RWTH Aachen University in the field of "Molecular Medicine".

Until further notice, she will continue to head a working group at the University Hospital at RWTH Aachen University, which is intensively involved in research into the therapy resistance of malignant stem cells.